BI 764532
Boehringer Ingelheim
['sclc']
#asco23 dll3 targeting agents in #sclc n=107 5 dlts, crs 59% overall efficacy seen across all subgroups including nec orr 25% 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl